Quantum Genomics S.A.

Quantum Genomics S.A.verified

QNNTF

Price:

$0.1

Market Cap:

$5.00M

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.

Industry

Biotechnology

IPO Date

2021-05-19

Stock Exchange

OTC

Ticker

QNNTF

The PE Ratio as of November 2025 (TTM) for Quantum Genomics S.A. (QNNTF) is -0.11

According to Quantum Genomics S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -73.21% compared to the average of -0.42 of the last 4 quarters.

Quantum Genomics S.A. (QNNTF) Historical PE Ratio (quarterly & annually)

How has QNNTF PE Ratio performed in the past?

The mean historical PE Ratio of Quantum Genomics S.A. over the last ten years is -7.07. The current -0.11 PE Ratio has changed 60.66% with respect to the historical average. Over the past ten years (40 quarters), QNNTF's PE Ratio was at its highest in in the December 2009 quarter at 0. The PE Ratio was at its lowest in in the December 2011 quarter at -69.30.

Quarterly (TTM)
Annual

Average

-7.07

Median

-6.68

Minimum

-15.57

Maximum

-0.16

Quantum Genomics S.A. (QNNTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Quantum Genomics S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 613.15%

Maximum Annual PE Ratio = -0.16

Minimum Annual Increase = -97.55%

Minimum Annual PE Ratio = -15.57

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.17613.15%
2022-0.16-97.55%
2021-6.667.99%
2020-6.16-7.91%
2019-6.69-4.37%
2018-7.0095.98%
2017-3.57-69.55%
2016-11.73-24.67%
2015-15.5729.72%
2014-12.01-24.22%

Quantum Genomics S.A. (QNNTF) Average PE Ratio

How has QNNTF PE Ratio performed in the past?

The current PE Ratio of Quantum Genomics S.A. (QNNTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.66

5-year avg

-4.17

10-year avg

-7.07

Quantum Genomics S.A. (QNNTF) PE Ratio vs. Peers

How is QNNTF’s PE Ratio compared to its peers?

Quantum Genomics S.A.’s PE Ratio is greater than Chimeric Therapeutics Limited (-0.76), less than Theralink Technologies, Inc. (-0.00), greater than Curative Biotechnology, Inc. (-2.45), less than LianBio (4.68), greater than BetterLife Pharma Inc. (-4.01), greater than PharmaTher Holdings Ltd. (-4.54), greater than Tristar Wellness Solutions Inc. (-6747.12), greater than ProText Mobility, Inc. (-1559.48), less than NanoSphere Health Sciences Inc. (0.17), greater than Glow Lifetech Corp. (-3.57),

Build a custom stock screener for Quantum Genomics S.A. (QNNTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum Genomics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Quantum Genomics S.A. (QNNTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Quantum Genomics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Quantum Genomics S.A.'s PE Ratio?

How is the PE Ratio calculated for Quantum Genomics S.A. (QNNTF)?

What is the highest PE Ratio for Quantum Genomics S.A. (QNNTF)?

What is the 3-year average PE Ratio for Quantum Genomics S.A. (QNNTF)?

What is the 5-year average PE Ratio for Quantum Genomics S.A. (QNNTF)?

How does the current PE Ratio for Quantum Genomics S.A. (QNNTF) compare to its historical average?